Elanco Animal Health Incorporated completes the sale of its Victoria, PEI, R&D Facility to The Center for Aquaculture Technologies Canada

Date Closed: 2/21/2020

Value: Undisclosed

On February 21, 2020, Elanco Animal Health Incorporated (NYSE: ELAN) completed the sale of its Victoria, Prince Edward Island (PEI) aqua research and development facility to The Center for Aquaculture Technologies Canada, a leading aquaculture R&D and contract research services company with an established presence in PEI.

The site was added to the Elanco footprint as part of the Novartis acquisition in 2015, and a source of innovative products and solutions to some of the industry’s greatest needs. Elanco will shift this important capability into its other existing R&D facilities.

Elanco, headquartered in Greenfield, Indiana, is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries.

BLG represented Elanco with a team led by Neil Hazan and Jordan Furfaro (Corporate) that included Leanne Laughlin, Kathryn Craner and Sara Lemieux (Commercial Real Estate).